Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.

Secreto G, Venturelli E, Meneghini E, Carcangiu ML, Paolini B, Agresti R, Pellitteri C, Berrino F, Gion M, Cogliati P, Saragò G, Micheli A.

BMC Cancer. 2012 Dec 14;12:599. doi: 10.1186/1471-2407-12-599.

2.

Expression of androgen receptors in primary breast cancer.

Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, Park BW, Lee KS.

Ann Oncol. 2010 Mar;21(3):488-92. doi: 10.1093/annonc/mdp510. Epub 2009 Nov 3.

3.

Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.

Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.

Int J Oncol. 2006 Jul;29(1):193-200.

PMID:
16773200
4.

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.

Fourkala EO, Zaikin A, Burnell M, Gentry-Maharaj A, Ford J, Gunu R, Soromani C, Hasenbrink G, Jacobs I, Dawnay A, Widschwendter M, Lichtenberg-Fraté H, Menon U.

Endocr Relat Cancer. 2012 Apr 10;19(2):137-47. doi: 10.1530/ERC-11-0310. Print 2012 Apr.

5.

Testosterone and biological characteristics of breast cancers in postmenopausal women.

Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2942-8. doi: 10.1158/1055-9965.EPI-09-0540. Epub 2009 Oct 20.

6.

Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.

Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A.

Int J Biol Markers. 2011 Oct-Dec;26(4):241-6. doi: 10.5301/JBM.2011.8883.

PMID:
22180173
7.

Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?

Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, Ozisik Y, Altundag K.

Am Surg. 2012 Sep;78(9):992-9.

PMID:
22964210
8.

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.

Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, Nagahara H, Sakurai K, Inoue T, Nishiguchi Y.

Int J Clin Oncol. 2008 Oct;13(5):431-5. doi: 10.1007/s10147-008-0770-6. Epub 2008 Oct 23.

PMID:
18946753
9.

Androgen receptor expression and breast cancer survival in postmenopausal women.

Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM.

Clin Cancer Res. 2011 Apr 1;17(7):1867-74. doi: 10.1158/1078-0432.CCR-10-2021. Epub 2011 Feb 15.

10.

Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.

Tokunaga E, Hisamatsu Y, Taketani K, Yamashita N, Akiyoshi S, Okada S, Tanaka K, Saeki H, Oki E, Aishima S, Oda Y, Morita M, Maehara Y.

Cancer Med. 2013 Dec;2(6):763-73. doi: 10.1002/cam4.138. Epub 2013 Sep 30.

11.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

12.

Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.

Tsang JY, Ni YB, Chan SK, Shao MM, Law BK, Tan PH, Tse GM.

Ann Surg Oncol. 2014 Jul;21(7):2218-28. doi: 10.1245/s10434-014-3629-2. Epub 2014 Mar 18.

PMID:
24639191
13.

Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.

Brentani MM, Franco EL, Oshima CT, Pacheco MM.

Int J Cancer. 1986 Nov 15;38(5):637-42.

PMID:
3770993
14.

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS.

Ann Oncol. 2011 Aug;22(8):1755-62. doi: 10.1093/annonc/mdq678. Epub 2011 Feb 10.

15.

Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.

Mishra AK, Agrawal U, Negi S, Bansal A, Mohil R, Chintamani C, Bhatnagar A, Bhatnagar D, Saxena S.

Indian J Med Res. 2012 Jun;135(6):843-52.

16.

Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC.

Cancer Res. 1979 May;39(5):1447-54.

17.

Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.

Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2003 Jun;9(6):2229-33.

18.

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.

Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris JM, Simila HA, Moore NL, Bentel JM, Ricciardelli C, Horsfall DJ, Butler LM, Tilley WD.

Cancer Res. 2005 Sep 15;65(18):8487-96.

19.

Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.

Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F.

Virchows Arch. 2010 Oct;457(4):467-76. doi: 10.1007/s00428-010-0964-y. Epub 2010 Aug 31.

PMID:
20809337
20.

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.

Witzel I, Graeser M, Karn T, Schmidt M, Wirtz R, Schütze D, Rausch A, Jänicke F, Milde-Langosch K, Müller V.

J Cancer Res Clin Oncol. 2013 May;139(5):809-16. doi: 10.1007/s00432-013-1382-8. Epub 2013 Feb 8.

PMID:
23392859
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk